EKSUNBI Trademark

Trademark Overview


On Wednesday, November 1, 2023, a trademark application was filed for EKSUNBI with the United States Patent and Trademark Office. The USPTO has given the EKSUNBI trademark a serial number of 79384560. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2024. This trademark is owned by SAMSUNG BIOEPIS CO., LTD.. The EKSUNBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparation...
eksunbi

General Information


Serial Number79384560
Word MarkEKSUNBI
Filing DateWednesday, November 1, 2023
Status700 - REGISTERED
Status DateTuesday, October 8, 2024
Registration Number7525854
Registration DateTuesday, October 8, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; medicated pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of crohn's disease; dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, December 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, December 14, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, June 7, 2024ASSIGNED TO EXAMINER
Friday, December 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 19, 2023APPLICATION FILING RECEIPT MAILED
Saturday, June 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2024NOTICE OF PUBLICATION
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 6, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 6, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, May 24, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, November 7, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB